Skip to main content

Advertisement

Log in

Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the role of transperineal template-guided mapping biopsy (TTMB) in patients with atypical small acinar proliferation (ASAP) diagnosed via transrectal ultrasound-guided needle biopsy (TRUS).

Methods

In total, 132 consecutive patients with TRUS-diagnosed ASAP underwent TTMB by means of an anatomic-based technique with sampling of 24 biopsy regions. For each of the 24 regions, 1–3 biopsy cores were obtained (depending on prostate size). No patient underwent pre-biopsy MRI imaging. The Gleason score, location of each positive biopsy core, the number of biopsy cores and percent involvement of each core were recorded. Anterior versus posterior cancer distribution was determined for both low- and high-grade (Gleason score ≥7) cancer.

Results

The mean patient age was 63.8 years with a mean PSA of 6.8 ng/mL. Of the 132 patients, 86 (65.2%) were diagnosed with prostate cancer. Of the entire cohort, 47 patients (54.7% of cancer patients and 35.6% of the entire cohort) were diagnosed with Gleason score ≥7. For both low- and high-grade cancers, the anterior gland and especially the anterior apex were the most common cancer locations.

Conclusion

In patients with ASAP, TTMB diagnosed prostate cancer in 65.2% of patients and 35.6% of the entire cohort had high-grade prostate cancer. A predilection for anterior-based cancers, especially the anterior apex, was identified. Our study may serve as a baseline reference for MRI-guided biopsy regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cheville JC, Reznicek MJ, Bostwick DG (1997) The focus of “atypical glands, suspicious for malignancy” in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol 108:633–640

    Article  CAS  PubMed  Google Scholar 

  2. Montironi R, Scattoni V, Mazzucchelli R, Lopez-Beltran A, Bostwick DG, Montorsi F (2006) Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as “atypical small acinar proliferation suspicious for but not diagnostic of malignancy”). Eur Urol 50:666–674

    Article  CAS  PubMed  Google Scholar 

  3. Borboroglu PG, Sur RL, Roberts JL, Amling CL (2001) Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol 166:866–870

    Article  CAS  PubMed  Google Scholar 

  4. Scattoni V, Roscigno M, Freschi M, Deho F, Raber M, Briganti A et al (2005) Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies. Arch Ital Urol Androl 77:31–36

    PubMed  Google Scholar 

  5. Epstein JI, Herawi M (2006) Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 175:820–834

    Article  PubMed  Google Scholar 

  6. Dorin RP, Wiener S, Harris CD, Wagner JR (2015) Prostate atypia: does repeat biopsy detect clinically significant prostate cancer? Prostate 75:673–678

    Article  PubMed  Google Scholar 

  7. Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ et al (2014) Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 12:1211–1219

    Article  CAS  PubMed  Google Scholar 

  8. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Van Der Kwast T et al (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013. Eur Urol 65:124–137

    Article  PubMed  Google Scholar 

  9. Leone A, Gershman B, Rotker K, Butler C, Fantasia J, Miller A et al (2016) Atypical small acinar proliferation (ASAP): is a repeat biopsy necessary ASAP? A multi-institutional review. Prostate Cancer Prostatic Dis 19:68–71

    Article  CAS  PubMed  Google Scholar 

  10. Warlick C, Feia K, Tomasini J, Iwamoto C, Lindgren B, Risk M (2015) Rate of Gleason 7 or higher prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation. Prostate Cancer Prostatic Dis 18:255–259

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Raskolnikov D, Rais-Bahrami S, George AK, Turkbey B, Shakir NA, Okoro C et al (2015) The role of image guided biopsy targeting in patients with atypical small acinar proliferation. J Urol 193:473–478

    Article  PubMed  Google Scholar 

  12. Leone L, Lacetera V, Montironi R, Cantoro U, Conti A, Sbrollini G et al (2014) Biopsy follow-up in patients with isolated atypical small acinar proliferation (ASAP) in prostate biopsy. Arch Ital Urol Androl 86:332–335

    Article  PubMed  Google Scholar 

  13. Lundstrom KJ, Drevin L, Carlsson S, Garmo H, Loeb S, Stattin P et al (2014) Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy. J Urol 192:1116–1122

    Article  PubMed  Google Scholar 

  14. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2013) Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. J Urol 189:867–870

    Article  PubMed  Google Scholar 

  15. Taira AV, Merrick GS, Galbreath RW, Andreini H, Taubenslag W, Curtis R et al (2010) Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis 13:71–77

    Article  CAS  PubMed  Google Scholar 

  16. Bittner N, Merrick GS, Butler WM, Bennett A, Galbreath RW (2013) Incidence and pathological features of prosate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy. J Urol 190:509–514

    Article  PubMed  Google Scholar 

  17. Ong W, Weerakoon M, Huang S, Paul E, Lawrentschuk N, Frydenberg M et al (2015) Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperienal Biopsy Collaboration experience. BJU Int 116:568–576

    Article  PubMed  Google Scholar 

  18. Huang S, Reeves F, Preece J, Satasivam P, Royce P, Grummet JP (2015) Significant impact of transperineal template biopsy of the prostate at a single tertiary institution. Urol Ann 7:428–432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Bittner N, Merrick GS, Taira A, Bennett A, Schattel A, Butler W et al (2016) Location and grade of prostate cancer diagnosed by transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy. Am J Clin Oncol (in press)

  20. Futterer JJ, Briganti A, Visschere PD, Emberton M, Giannarini G, Kirkham A et al (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68:1045–1053

    Article  PubMed  Google Scholar 

Download references

Authors’ contributions

G.S.M., MD, contributed to protocol/project development, data collection, data analysis and manuscript writing, R.W.G., PhD, contributed to data management and data analysis, A.B., BS, contributed to data management and data analysis, W.M. B., PhD, contributed to data management, data analysis and manuscript editing and E.A., MD, contributed to data collection and manuscript editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregory S. Merrick.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Human and animal rights

This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Merrick, G.S., Galbreath, R.W., Bennett, A. et al. Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation. World J Urol 35, 1009–1013 (2017). https://doi.org/10.1007/s00345-016-1976-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-016-1976-2

Keywords

Navigation